Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/600276 stock hub

SHA/600276 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/600276is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

350.4B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/600276

In the news

Latest news · SHA/600276

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E37.8

P25 17.1P50 24.2P75 37.8

Trailing P/E43.3

P25 23.5P50 41.3P75 83.2

ROE14.5

P25 -0.9P50 4.1P75 8.8

ROIC34.4

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/600276 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

239

Groups with data

Currency

CNY

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	20,602
Employees Change	364%
Employees Change Percent	1.8
Enterprise value	CNY 310.4B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE0000014W7
Last refreshed	2026-05-10
Market cap	CNY 350.4B
Price	CNY 52.8
Price currency	CNY
Rev Per Employee	1,580,641.22x
Sector	Healthcare
Sic	2834
Symbol	sha/600276
Website	https://www.hengrui.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.32%
EV Earnings	38.23x
EV/EBIT	35.96x
EV/EBITDA	32.69x
EV/FCF	36.51x
EV/Sales	9.53x
FCF yield	2.43%
Forward P/E	37.77x
P/B ratio	5.46x
P/E ratio	43.25x
P/S ratio	10.76x
PE Ratio10 Y	61.6x
PE Ratio3 Y	56.68x
PE Ratio5 Y	59.09x
PEG ratio	38.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26.5%
EBITDA Margin	29.03%
FCF margin	26.11%
Gross margin	86.27%
Gross Profit	CNY 28.1B
Gross Profit Growth	11.54%
Gross Profit Growth Q	14.87%
Gross Profit Growth3 Y	16.47%
Gross Profit Growth5 Y	1.87%
Net Income	CNY 8.1B
Net Income Growth	18.67%
Net Income Growth Q	21.78%
Net Income Growth Quarters	14%
Net Income Growth Years	3%
Net Income Growth3 Y	27.6%
Net Income Growth5 Y	4.52%
Pretax Margin	28.22%
Profit Margin	24.93%
Profit Per Employee	CNY 394,101
Profitable Years	29
ROA	8.8
Roa5y	6.83
ROCE	13.14
ROE	14.54
Roe5y	12.69
ROIC	34.38
Roic5y	23.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	14.13%
Cagr15y	16.07%
Cagr1y	2.88%
Cagr20y	24.12%
Cagr3y	4.03%
Cagr5y	-4.2%
Div CAGR10	20.53%
Div CAGR3	7.72%
Div CAGR5	0.85%
EPS Growth Quarters	12
EPS Growth Years	3
FCF Growth	84.3%
FCF Growth5 Y	45.81%
OCF Growth	70.55%
OCF Growth Q	41.66%
OCF Growth10 Y	16.72%
OCF Growth3 Y	104.99%
OCF Growth5 Y	40.59%
Revenue Growth	11.55x
Revenue Growth Q	12.98x
Revenue Growth Quarters	13x
Revenue Growth Years	3x
Revenue Growth3 Y	15.22x
Revenue Growth5 Y	2.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.53
Assets	CNY 71.3B
Cash	CNY 40.6B
Current Assets	CNY 52B
Current Liabilities	CNY 5.6B
Debt	CNY 67.5M
Debt EBITDA	CNY 0.01
Debt Equity	CNY 0
Debt FCF	CNY 0.01
Equity	CNY 64.1B
Interest Coverage	2,228.3
Liabilities	CNY 7.1B
Long Term Assets	CNY 19.2B
Long Term Liabilities	CNY 1.5B
Net Cash	CNY 40.6B
Net Cash By Market Cap	CNY 11.58
Net Cash Growth	68.42%
Net Debt EBITDA	CNY -4.29
Net Debt Equity	CNY -0.63
Net Debt FCF	CNY -4.77
Tangible Book Value	CNY 61.4B
Tangible Book Value Per Share	CNY 9.14
WACC	5.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.23
Inventory Turnover	1.69
Net Working Capital	CNY 5.8B
Quick ratio	8.36
Working Capital	CNY 46.4B
Working Capital Turnover	CNY 0.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.2
Dividend Years	25
Dividend Yield	0.38%
Ex Div Date	2025-05-23
Last Dividend	CNY 0.2
Payout Frequency	Annual
Payout Ratio	15.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	274.93%
1Y total return	2.87%
200-day SMA	61.03
3Y total return	12.58%
50-day SMA	55.53
50-day SMA vs 200-day SMA	50under200
5Y total return	-19.32%
All Time High	97.39
All Time High Change	-45.79%
All Time High Date	2021-01-08
All Time Low	0.24
All Time Low Change	21,646.29%
All Time Low Date	2003-10-10
ATR	1.43
Beta	0.17
Beta1y	0.14
Beta2y	0.38
Ch YTD	-11.36
High	53.92
High52	74.04
High52 Date	2025-09-09
High52ch	-28.69%
Low	52.68
Low52	50.2
Low52 Date	2025-05-12
Low52ch	5.18%
Ma50ch	-4.92%
Price vs 200-day SMA	-13.48%
RSI	36.26
RSI Monthly	48.75
RSI Weekly	35.3
Sharpe ratio	0.27x
Sortino ratio	0.62
Total Return	0.38%
Tr YTD	-11.36
Tr15y	835.12%
Tr1m	-5.92%
Tr1w	-1.55%
Tr3m	-7.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 8.6B
Operating Income Growth	22.87
Operating Income Growth Q	26.86
Operating Income Growth3 Y	41.71
Operating Income Growth5 Y	5.99
Operating margin	26.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,722,932,709%
Net Borrowing	-48,694,661
Shares Insiders	0.12%
Shares Institutions	28.41%
Shares Out	6,621,113,324

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 8.5B
Average Volume	65,387,947x
Bv Per Share	9.48
CAPEX	CNY -3B
Ch10y	264
Ch15y	798.9
Ch1m	-5.92
Ch1w	-1.55
Ch1y	2.5
Ch20y	5,715.6
Ch3m	-7.87
Ch3y	11.23
Ch5y	-20.79
Ch6m	-14.26
Change	-1.64%
Change From Open	-2
Close	53.68
Days Gap	0.37
Depreciation Amortization	822,430,633
Dollar Volume	4,236,749,352
Earnings Date	2026-08-20
EBIT	CNY 8.6B
EBITDA	CNY 9.5B
EPS	CNY 1.22
F Score	4
FCF	CNY 8.5B
FCF EV Yield	2.74x
FCF Per Share	CNY 1.28
Financing CF	8,257,049,630
Fiscal Year End	December
Founded	1,970
Graham Number	16.31017
Graham Upside	-69.11
Income Tax	CNY 1.1B
Investing CF	-2,932,570,815
Is Primary Listing	1
Last Earnings Date	2026-03-25
Last Report Date	2026-03-31
Last Split Date	2021-06-10
Last Split Type	Forward
Lynch Fair Value	CNY 6.12
Lynch Upside	-88.42
Ma150	60.32
Ma150ch	-12.46%
Ma20	55.68
Ma20ch	-5.17%
Net CF	16,051,670,533
Next Earnings Date	2026-08-20
Open	53.88
P FCF Ratio	41.22
P OCF Ratio	30.56
Payment Date	2025-05-23
Position In Range	9.68
Ppne	8,128,268,300
Price Date	2026-05-08
Price EBITDA	CNY 37.07
Ptbv Ratio	5.71
Relative Volume	1.24x
Revenue	32,564,370,391x
Tax By Revenue	3.28x
Tax Rate	11.62%
Tr20y	7,431.28%
Tr6m	-14.26%
Volume	80,241,465
Z Score	35.34

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/600276 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$0.20 annual per share

Payout ratio

+15.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+0.9%

0 consecutive years of growth

Total shareholder yield

+0.4%

Next ex-dividend date: 2025-05-23

Performance

SHA/600276 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/600276?

Insider, institutional, and short-interest positioning.

Institutional ownership

+28.4%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

SHA/600276 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.3

Neutral momentum band

Price vs 200-day MA

-13.5%

50/200-day relationship not available

Beta (5Y)

0.17

Less volatile than the market

Sharpe ratio

0.27

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/600276

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600276 stock rating?

sha/600276 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600276 analysis?

The full report lives at /stocks/sha/600276/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600276?

The latest report frames sha/600276 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600276 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.